Press release
Global Advanced Therapy Medicinal Products Market Size to grow at a CAGR of 14.17% by 2032, Evaluates DelveInsight
DelveInsight's "Advanced Therapy Medicinal Products Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Advanced Therapy Medicinal Products companies actively working in the market.
To know more about why North America is leading the market growth in the Advanced Therapy Medicinal Products market, get a snapshot of the report Advanced Therapy Medicinal Products Market Trends
https://www.delveinsight.com/sample-request/advanced-therapy-medicinal-products-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Advanced Therapy Medicinal Products Overview
Advanced Therapy Medicinal Products (ATMPs) are innovative medicines that use genes, cells, or tissue engineering to treat or prevent diseases. They include gene therapy, cell therapy, and tissue-engineered products, offering potential cures for conditions that are currently difficult or impossible to treat. ATMPs work by repairing, replacing, or regenerating damaged cells and tissues, and are at the forefront of personalized and regenerative medicine.
DelveInsight Analysis: The advanced therapy medicinal products (ATMP) market size was valued at USD 30,778.72 million in 2024 and is projected to expand at a CAGR of 14.17% from 2025 to 2032.
Advanced Therapy Medicinal Products Market Insights
Geographically, North America is projected to hold the largest share of the advanced therapy medicinal products (ATMP) market in 2024, driven by the increasing incidence of cancer and the growing R&D efforts by major industry players in the region. These factors are expected to significantly contribute to the expansion of the ATMP market across North America.
To read more about the latest highlights related to Advanced Therapy Medicinal Products, get a snapshot of the key highlights entailed in the Advanced Therapy Medicinal Products Insights
https://www.delveinsight.com/report-store/advanced-therapy-medicinal-products-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Advanced Therapy Medicinal Products Market Report
• In April 2024, Pfizer Inc. announced that it received US FDA approval for BEQVEZ (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B. BEQVEZ is an adeno-associated virus (AAV)-based one-time treatment gene therapy developed for patients suffering from hemophilia B.
• In February 2024, BioNTech and Autolus Therapeutics announced a strategic collaboration to develop CAR-T cell therapy aimed at advancing their pipeline and expanding late-stage programs. Through this partnership, both companies focused on accelerating pipeline programs to develop advanced therapies for multiple cancer indications.
• In January 2022, Fate Therapeutics announced that it received FDA clearance for an Investigational New Drug (IND) application for FT536. FT536 is a chimeric antigen receptor (CAR) NK cell product candidate for the treatment of advanced solid tumors.
• In June 2022, Bristol Myers Squibb announced that the FDA approved Breyanzi (lisocabtagene maraleucel). Breyanzi is a chimeric antigen receptor (CAR) T-cell therapy for the treatment of adult patients with large B-cell lymphoma (LBCL) and other lymphatic cancers
• Thus, owing to such developments in the market, rapid growth will be observed in the Advanced Therapy Medicinal Products market during the forecast period
Key Players in the Advanced Therapy Medicinal Products Market
Some of the key market players operating in the Advanced Therapy Medicinal Products market include- Pfizer Inc., Novartis AG, Gilead Sciences, Inc., Kolon TissueGene, Inc., Bluebird Bio, Inc., F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Organogenesis Inc., BioNTech, Regeneron Pharmaceuticals Inc., ALLOGENE THERAPEUTICS, CRISPR Therapeutics, Autolus Therapeutics, Anixa Biosciences, Inc., Amgen Inc., Intellia Therapeutics, Inc., Adaptimmune, Voyager Therapeutics Inc., Sangamo Therapeutics, Inc., Biogen, and others.
Which MedTech key players in the Advanced Therapy Medicinal Products market are set to emerge as the trendsetter explore @ Key Advanced Therapy Medicinal Products Companies
https://www.delveinsight.com/sample-request/advanced-therapy-medicinal-products-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Advanced Therapy Medicinal Products Market Landscape
CAR-T cell therapy represents a leading example of personalized medicine, involving the extraction, genetic modification, activation, expansion, and reinfusion of a patient's own T cells to target cancer cells effectively. This innovative approach has encouraged extensive research by major industry players. For instance, in March 2024, Bristol-Myers Squibb received accelerated approval from the U.S. FDA for Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed CAR-T cell therapy for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
Moreover, cell therapy utilizes the body's innate mechanisms, such as immune response and gene repair, making it a cornerstone of personalized medicine. The expanding adoption and advancement of cell-based treatments, including stem cell therapy, CAR-T therapy, and tissue engineering, are expected to propel segment growth, thereby driving the overall expansion of the advanced therapy medicinal products (ATMP) market during the forecast period.
Scope of the Advanced Therapy Medicinal Products Market Report
• Coverage: Global
• Study Period: 2022-2032
• Advanced Therapy Medicinal Products Market Segmentation By Type: Gene-Therapy Medicines, Cell Therapy Medicines, Tissue Engineered Products, Combined ATMPs
• Advanced Therapy Medicinal Products Market Segmentation By Indication: Oncology, Cardiology, Neurology, Genetic Disorders, Infectious Diseases, Metabolic Disease, and Others
• Advanced Therapy Medicinal Products Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Advanced Therapy Medicinal Products Companies: Pfizer Inc., Novartis AG, Gilead Sciences, Inc., Kolon TissueGene, Inc., Bluebird Bio, Inc., F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Organogenesis Inc., BioNTech, Regeneron Pharmaceuticals Inc., ALLOGENE THERAPEUTICS, CRISPR Therapeutics, Autolus Therapeutics, Anixa Biosciences, Inc., Amgen Inc., Intellia Therapeutics, Inc., Adaptimmune, Voyager Therapeutics Inc., Sangamo Therapeutics, Inc., Biogen, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Advanced Therapy Medicinal Products market will grow by 2032? Click to get a snapshot of the Advanced Therapy Medicinal Products Market Analysis
https://www.delveinsight.com/sample-request/advanced-therapy-medicinal-products-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Advanced Therapy Medicinal Products Market Size to grow at a CAGR of 14.17% by 2032, Evaluates DelveInsight here
News-ID: 4269718 • Views: …
More Releases from DelveInsight Business Research
Sepsis Pipeline 2025: Detailed Clinical Trials and FDA-Approved Therapies Review …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Sepsis pipeline constitutes 25+ key companies continuously working towards developing 30+ Sepsis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Sepsis Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Sepsis Market.
The Sepsis Pipeline report embraces in-depth…
Actinic Keratosis Market to Experience Notable Growth in Forecast Span by 2034, …
The Actinic Keratosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Actinic Keratosis pipeline products will significantly revolutionize the Actinic Keratosis market dynamics.
DelveInsight's "Actinic Keratosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Actinic Keratosis, historical and forecasted epidemiology as well as the Actinic Keratosis market trends in the United…
Cystinosis Market Insights Highlight Expanding Outlook Till 2032, DelveInsight E …
The Cystinosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Cystinosis pipeline products will significantly revolutionize the Cystinosis market dynamics.
DelveInsight's "Cystinosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Cystinosis, historical and forecasted epidemiology as well as the Cystinosis market trends in the United States, EU5 (Germany, Spain, Italy, France,…
Allergic Rhinitis Market to Evolve Rapidly Over the Next Decade by 2034, DelveIn …
DelveInsight's "Allergic Rhinitis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Allergic Rhinitis, historical and forecasted epidemiology as well as the Allergic Rhinitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Allergic Rhinitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Allergic Rhinitis Market Forecast
https://www.delveinsight.com/sample-request/allergic-rhinitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts…
More Releases for Therapy
Music Therapy Market Growth Potential is Booming Now: World Federation of Music …
HTF MI just released the Global Music Therapy Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2033. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies in Music Therapy Market are: Music Therapy Services (United…
Visual Arts Therapy Market Future Business Opportunities 2024-2031 | American Ar …
A recent report titled "Visual Arts Therapy Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report additionally features a comprehensive table of contents, figures, tables, and charts, as well as an analysis of the data. The Visual…
Hair Transplant Market by Therapy (Platelet-Rich Plasma Therapy (PRP), Stem Cell …
Hair transplant refers to the market for surgical procedures aimed at restoring hair growth in individuals experiencing hair loss or baldness. These procedures involve the transplantation of hair follicles from one part of the body to the balding or thinning areas.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-hair-transplant-market
The expansion of biotechnology sector across the globe, acts as one of the major factors driving the growth of global hair transplant market. The increase in the…
Melanoma Therapeutics Market By Chemotherapy, Biologic therapy, Targeted therapy …
Melanoma market has witnessed an unprecedented boost in market size, owing to a dynamically evolving nature of melanoma treatments over the past few years. The high demand of novel early stage and advanced melanoma therapies along with a booming patient base, has created an impending need for better therapies in the melanoma market. Although, a plethora of treatment options are available today, several immunotherapies and combination therapies are expected to…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights:
• Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026
• Cell Therapy Clinical Trial Insight by Indication, Company & Country
• Global Cell Therapy Clinical Pipeline: 767 Cell Therapies
• Globally Marketed Cell Therapies: 25 Cell Therapies
• Maximum Number of Marketed Cell Therapies In USA: 15 Therapies
• Price & Product Insight By Region/Country
• Regional Analysis of the Cell Therapy Market
Download…
